癌症干细胞治疗市场规模 - 按类型(针对癌症干细胞、基于干细胞)、癌症类型(乳腺癌、肺癌、大肠直肠癌、前列腺癌)、最终用户、全球预测(2023-2032)
市场调查报告书
商品编码
1389729

癌症干细胞治疗市场规模 - 按类型(针对癌症干细胞、基于干细胞)、癌症类型(乳腺癌、肺癌、大肠直肠癌、前列腺癌)、最终用户、全球预测(2023-2032)

Cancer Stem Cells Therapy Market Size - By Type (Targeted Cancer Stem Cells, Stem Cells-based), Cancer Type (Breast, Lung, Colorectal, Prostrate), End-user, Global Forecast (2023- 2032)

出版日期: | 出版商: Global Market Insights Inc. | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

在蓬勃发展的研发努力的推动下,2023 年至 2032 年间,全球癌症干细胞治疗市场的CAGR将达到 10.2%。这些努力着重于创新疗法和治疗方法,旨在从根本上揭示癌症的复杂性。例如,2023 年 11 月,在《基因与疾病》综述中,ICMR-国家营养研究所专家提议重新利用非癌症药物来针对难以捉摸的癌症干细胞 (CSC)。该策略利用了已批准的药物,这些药物已被证明对其他疾病的安全性,为创新癌症治疗提供了更安全、更快捷的途径。 CSC 对于确定肿瘤侵袭性和抵抗标准治疗至关重要,这凸显了对更多客製化疗法的需求。这项突破为客製化癌症治疗铺平了道路。

随着对突破性发现的热切追求,该领域出现了前所未有的激增,推动了对标靶治疗和精准医学的需求。这种探索和创新的激增不仅扩大了治疗选择,还强调了癌症干细胞治疗市场前景在彻底改变癌症治疗范式中的关键作用。

整个癌症干细胞治疗市场根据癌症类型、最终用户和地区进行分类。

大肠直肠癌细分市场将在 2023 年至 2032 年间经历重大发展。大肠直肠癌的盛行率和挑战性性质凸显了针对癌症干细胞的创新疗法的必要性。随着研究揭示这些细胞在肿瘤侵袭性和抗药性中的复杂作用,市场对精准治疗的需求不断增长,从而提高了癌症干细胞治疗市场份额在解决大肠直肠癌的重要性。

从 2023 年到 2032 年,专科中心细分市场的CAGR将达到显着水平。这些中心以其专业知识和尖端技术而闻名,推动了针对癌症干细胞的创新疗法的需求。随着他们开创新方法并展示改善的结果,市场见证了对这些专业治疗的需求激增,凸显了专业中心在塑造癌症干细胞治疗市场前景方面的关键作用。

亚太地区癌症干细胞治疗产业将在2023年至2032年呈现出值得称讚的CAGR。随着癌症盛行率的上升,特别是在中国和印度等国家,对针对癌症干细胞的创新疗法的需求日益增长。随着该地区研究和开发的扩大,加上对个人化医疗的关注,市场对客製化治疗的需求激增,塑造了亚太地区癌症干细胞治疗的模式。

例如,2023 年 11 月,北海道大学遗传医学研究所由 Haruka Wada 副教授领导的一项研究深入研究了癌症干细胞如何在小鼠模型中逃避免疫系统,从而引发巨噬细胞衰老。这些免疫细胞通常会引发癌细胞死亡,但由于癌症干细胞的影响而出现老化。 《癌症免疫治疗杂誌》发表了他们的研究结果。

目录

第 1 章:方法与范围

第 2 章:执行摘要

第 3 章:癌症干细胞治疗产业洞察

  • 产业格局,2018 - 2032
  • 产业影响力
    • 成长动力
      • 癌症病例增加
      • 增加私人和公共倡议
      • 人们对干细胞疗法的可用性的认识不断提高
      • 增加研发计划
    • 产业陷阱与挑战
      • 相关副作用
      • 干细胞治疗费用高
  • 成长潜力分析
  • COVID-19 影响分析
  • 监管环境
  • 波特的分析
  • PESTEL分析

第 4 章:竞争格局

  • 介绍
  • 公司矩阵分析
  • 主要市场参与者的竞争分析,
  • 竞争定位矩阵
  • 战略仪錶板

第 5 章:癌症干细胞治疗市场规模与预测:按类型,2018-2032

  • 主要动向:依类型
  • 标靶癌症干细胞
  • 基于干细胞的治疗
    • 同种异体干细胞
    • 自体干细胞

第 6 章:癌症干细胞治疗市场规模与预测:依癌症类型 2018-2032

  • 主要动力向:按癌症类型
  • 胸部
  • 大肠直肠
  • 伏地
  • 其他癌症类型

第 7 章:癌症干细胞治疗市场规模和预测:按最终用户划分,2018-2032 年

  • 主要动向:由最终用户
  • 医院
  • 专科中心
  • 其他最终用户

第 8 章:癌症干细胞治疗市场规模及预测:按地区划分,2018-2032

  • 主要动向:按地区
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 中东和非洲其他地区

第 9 章:公司简介

  • Gamida Cells
  • AbbVie Inc
  • Astellas Pharma Inc
  • Novadip Biosciences
  • ReNeuron Group plc
  • Celyad
  • Adna GmBH
  • Thermo Fisher Scientific
  • Genentech Inc
  • Merck KGaA
Product Code: 7152

Global Cancer Stem Cells Therapy Market will witness 10.2% CAGR between 2023 and 2032, propelled by burgeoning research and development endeavors. These efforts, focusing on innovative therapeutics and treatments, aim to unravel the complexities of cancer at its core. For instance, in November 2023, in a Genes & Diseases review, ICMR-National Institute of Nutrition experts proposed the repurposing of non-cancer drugs to target elusive cancer stem cells (CSCs). This strategy taps into approved drugs with proven safety for other conditions, offering a safer and quicker path to innovate cancer therapy. CSCs, crucial in determining tumor aggressiveness and resisting standard treatments, underscore the need for more customized therapies. This breakthrough paves the way for tailored cancer treatments.

With an ardent pursuit of breakthrough discoveries, the field witnesses an unprecedented surge, driving the demand for targeted therapies and precision medicine. This surge in exploration and innovation not only amplifies therapeutic options but also underscores the critical role of the cancer stem cells therapy market outlook in revolutionizing cancer treatment paradigms.

The overall Cancer Stem Cells Therapy Market is classified based on cancer type, end-user, and region.

Colorectal cancer segment will undergo significant development from 2023 to 2032. With its prevalence and challenging nature, colorectal cancer underscores the necessity for innovative therapies targeting cancer stem cells. As research unravels the intricacies of these cells' role in tumor aggressiveness and resistance, the market responds with a growing need for precision therapies, elevating the significance of cancer stem cells therapy market share in addressing colorectal cancer.

Specialty centers segment will register a noteworthy CAGR from 2023 to 2032. These centers, renowned for their expertise and cutting-edge technology, fuel the demand for innovative therapies targeting cancer stem cells. As they pioneer new approaches and demonstrate improved outcomes, the market witnesses a surge in demand for these specialized treatments, highlighting the pivotal role of specialty centers in shaping the cancer stem cells therapy market outlook.

Asia Pacific cancer stem cells therapy industry will showcase a commendable CAGR from 2023 to 2032. With a rising prevalence of cancer, especially in countries like China and India, there's a growing need for innovative therapies targeting cancer stem cells. As research and development expand in this region, coupled with a focus on personalized medicine, the market witnesses a surge in demand for tailored treatments, shaping the cancer stem cells therapy landscape in Asia-Pacific.

For instance, in November 2023, a study by Hokkaido University's Institute for Genetic Medicine, led by Associate Professor Haruka Wada, delved into how cancer stem cells evade the immune system in mouse models, triggering aging in macrophages. These immune cells typically initiate cancer cell death but were shown to undergo senescence due to the influence of cancer stem cells. The Journal for ImmunoTherapy of Cancer published their discoveries.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculation
  • 1.4 Covid-19 impact analysis at global level
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Global cancer stem cells therapy market 360 degree synopsis, 2018 - 2032
  • 2.2 Business trends
  • 2.3 Region trends
  • 2.4 Type trends
  • 2.5 Cancer type trends
  • 2.6 End-user trends

Chapter 3 Cancer Stem Cells Therapy Industry Insights

  • 3.1 Industry landscape, 2018 - 2032 (USD Million)
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing cases of cancer
      • 3.2.1.2 Increasing private and public initiatives
      • 3.2.1.3 Rising awareness regarding availability of stem cell therapy
      • 3.2.1.4 Increasing research & development programs
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Associated side-effects
      • 3.2.2.2 High cost of stem cell therapy
  • 3.3 Growth potential analysis
    • 3.3.1 By type
    • 3.3.2 By cancer type
    • 3.3.3 By end-user
  • 3.4 COVID-19 impact analysis
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Competitive analysis of major market players,
  • 4.4 Competitive positioning matrix, 2022
  • 4.5 Strategic dashboard, 2022

Chapter 5 Cancer Stem Cells Therapy Market Size and Forecast, By Type, 2018-2032 (USD Million)

  • 5.1 Key trends, by type
  • 5.2 Targeted cancer stem cells
  • 5.3 Stem cells-based therapy
    • 5.3.1 Allogenic stem cell
    • 5.3.2 Autologous stem cell

Chapter 6 Cancer Stem Cells Therapy Market Size and Forecast, By Cancer Type 2018-2032 (USD Million)

  • 6.1 Key trends, by cancer type
  • 6.2 Breast
  • 6.3 Lung
  • 6.4 Colorectal
  • 6.5 Prostrate
  • 6.6 Stomach
  • 6.7 Liver
  • 6.8 Other cancer types

Chapter 7 Cancer Stem Cells Therapy Market Size and Forecast, By End-user, 2018-2032 (USD Million)

  • 7.1 Key trends, by end-user
  • 7.2 Hospitals
  • 7.3 Specialty centres
  • 7.4 Other end-users

Chapter 8 Cancer Stem Cells Therapy Market Size and Forecast, By Region, 2018-2032 (USD Million)

  • 8.1 Key trends, by region
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Rest of Latin America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 South Africa
    • 8.6.3 Rest of Middle East & Africa

Chapter 9 Company Profiles

  • 9.1 Gamida Cells
  • 9.2 AbbVie Inc
  • 9.3 Astellas Pharma Inc
  • 9.4 Novadip Biosciences
  • 9.5 ReNeuron Group plc
  • 9.6 Celyad
  • 9.7 Adna GmBH
  • 9.8 Thermo Fisher Scientific
  • 9.9 Genentech Inc
  • 9.10 Merck KGaA

Data Tables

  • TABLE 1 Market revenue, by type (2022)
  • TABLE 2 Market revenue, by cancer type (2022)
  • TABLE 3 Market revenue, by end-user (2022)
  • TABLE 4 Market share, by region (2022)
  • TABLE 5 Global cancer stem cells therapy market size, by region, 2018 - 2022 (USD Million)
  • TABLE 6 Global cancer stem cells therapy market size, by region, 2023 - 2032 (USD Million)
  • TABLE 7 Global cancer stem cells therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 8 Global cancer stem cells therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 9 Global cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 10 Global cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 11 Global cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 12 Global cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 13 Targeted cancer stem cells market size, 2018 - 2022 (USD Million)
  • TABLE 14 Targeted cancer stem cells market size, 2023 - 2032 (USD Million)
  • TABLE 15 Stem cells-based therapy market size, 2018 - 2022 (USD Million)
  • TABLE 16 Stem cells-based therapy market size, 2023 - 2032 (USD Million)
  • TABLE 17 Allogenic stem cell market size, 2018 - 2022 (USD Million)
  • TABLE 18 Allogenic stem cell market size, 2023 - 2032 (USD Million)
  • TABLE 19 Autologous stem cell market size, 2018 - 2022 (USD Million)
  • TABLE 20 Autologous stem cell market size, 2023 - 2032 (USD Million)
  • TABLE 21 Breast market size, 2018 - 2022 (USD Million)
  • TABLE 22 Breast market size, 2023 - 2032 (USD Million)
  • TABLE 23 Lung market size, 2018 - 2022 (USD Million)
  • TABLE 24 Lung market size, 2023 - 2032 (USD Million)
  • TABLE 25 Colorectal market size, 2018 - 2022 (USD Million)
  • TABLE 26 Colorectal market size, 2023 - 2032 (USD Million)
  • TABLE 27 Prostrate market size, 2018 - 2022 (USD Million)
  • TABLE 28 Prostrate market size, 2023 - 2032 (USD Million)
  • TABLE 29 Stomach market size, 2018 - 2022 (USD Million)
  • TABLE 30 Stomach market size, 2023 - 2032 (USD Million)
  • TABLE 31 Liver market size, 2018 - 2022 (USD Million)
  • TABLE 32 Liver market size, 2023 - 2032 (USD Million)
  • TABLE 33 Other cancer types market size, 2018 - 2022 (USD Million)
  • TABLE 34 Other cancer types market size, 2023 - 2032 (USD Million)
  • TABLE 35 Hospitals market size, 2018 - 2022 (USD Million)
  • TABLE 36 Hospitals market size, 2023 - 2032 (USD Million)
  • TABLE 37 Specialty centers market size, 2018 - 2022 (USD Million)
  • TABLE 38 Specialty centers market size, 2023 - 2032 (USD Million)
  • TABLE 39 Other end-users market size, 2018 - 2022 (USD Million)
  • TABLE 40 Other end-users market size, 2023 - 2032 (USD Million)
  • TABLE 41 North America cancer stem cells therapy market size, by country, 2018 - 2022 (USD Million)
  • TABLE 42 North America cancer stem cells therapy market size, by country, 2023 - 2032 (USD Million)
  • TABLE 43 North America cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 44 North America cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 45 North America cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 46 North America cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 47 North America cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 48 North America cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 49 North America cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 50 North America cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 51 U.S. cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 52 U.S. cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 53 U.S. cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 54 U.S. cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 55 U.S. cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 56 U.S. cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 57 U.S. cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 58 U.S. cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 59 Canada cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 60 Canada cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 61 Canada cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 62 Canada cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 63 Canada cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 64 Canada cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 65 Canada cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 66 Canada cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 67 Europe cancer stem cells therapy market size, by country, 2018 - 2022 (USD Million)
  • TABLE 68 Europe cancer stem cells therapy market size, by country, 2023 - 2032 (USD Million)
  • TABLE 69 Europe cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 70 Europe cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 71 Europe cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 72 Europe cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 73 Europe cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 74 Europe cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 75 Europe cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 76 Europe cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 77 Germany cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 78 Germany cancer stem cells therapy market size, by type, 2025- 2032 (USD Million)
  • TABLE 79 Germany cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 80 Germany cancer stem cells therapy market size, by stem cells-based therapy, 2025- 2032 (USD Million)
  • TABLE 81 Germany cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 82 Germany cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 83 Germany cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 84 Germany cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 85 UK cancer stem cells therapy market size, by type, 2018- 2024 (USD Million)
  • TABLE 86 UK cancer stem cells therapy market size, by type, 2025- 2032 (USD Million)
  • TABLE 87 UK cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2023 (USD Million)
  • TABLE 88 UK cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 89 UK cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 90 UK cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 91 UK cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 92 UK cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 93 France cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 94 France cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 95 France cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 96 France cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 97 France cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 98 France cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 99 France cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 100 France cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 101 Italy cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 102 Italy cancer stem cells therapy market size, by type, 2025- 2032 (USD Million)
  • TABLE 103 Italy cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 104 Italy cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 105 Italy cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 106 Italy cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 107 Italy cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 108 Italy cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 109 Spain cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 110 Spain cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 111 Spain cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 112 Spain cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 113 Spain cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 114 Spain cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 115 Spain cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 116 Spain cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 117 Rest of Europe cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 118 Rest of Europe cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 119 Rest of Europe cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 120 Rest of Europe cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 121 Rest of Europe cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 122 Rest of Europe cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 123 Rest of Europe cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 124 Rest of Europe cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 125 Asia Pacific cancer stem cells therapy market size, by country, 2018 - 2022 (USD Million)
  • TABLE 126 Asia Pacific cancer stem cells therapy market size, by country, 2023 - 2032 (USD Million)
  • TABLE 127 Asia Pacific cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 128 Asia Pacific cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 129 Asia Pacific cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 130 Asia Pacific cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 131 Asia Pacific cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 132 Asia Pacific cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 133 Asia Pacific cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 134 Asia Pacific cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 135 China cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 136 China cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 137 China cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 138 China cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 139 China cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 140 China cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 141 China cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 142 China cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 143 Japan cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 144 Japan cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 145 Japan cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 146 Japan cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 147 Japan cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 148 Japan cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 149 Japan cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 150 Japan cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 151 India cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 152 India cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 153 India cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 154 India cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 155 India cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 156 India cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 157 India cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 158 India cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 159 Australia cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 160 Australia cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 161 Australia cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 162 Australia cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 163 Australia cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 164 Australia cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 165 Australia cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 166 Australia cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 167 Rest of Asia Pacific cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 168 Rest of Asia Pacific cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 169 Rest of Asia Pacific cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 170 Rest of Asia Pacific cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 171 Rest of Asia Pacific cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 172 Rest of Asia Pacific cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 173 Rest of Asia Pacific cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 174 Rest of Asia Pacific cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 175 Latin America cancer stem cells therapy market size, by country, 2018 - 2022 (USD Million)
  • TABLE 176 Latin America cancer stem cells therapy market size, by country, 2023 - 2032 (USD Million)
  • TABLE 177 Latin America cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 178 Latin America cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 179 Latin America cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 180 Latin America cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 181 Latin America cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 182 Latin America cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 183 Latin America cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 184 Latin America cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 185 Brazil cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 186 Brazil cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 187 Brazil cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 188 Brazil cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 189 Brazil cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 190 Brazil cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 191 Brazil cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 192 Brazil cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 193 Mexico cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 194 Mexico cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 195 Mexico cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 196 Mexico cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 197 Mexico cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 198 Mexico cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 199 Mexico cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 200 Mexico cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 201 Rest of Latin America cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 202 Rest of Latin America cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 203 Rest of Latin America cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 204 Rest of Latin America cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 205 Rest of Latin America cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 206 Rest of Latin America cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 207 Rest of Latin America cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 208 Rest of Latin America cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 209 Middle East & Africa cancer stem cells therapy market size, by country, 2018 - 2022 (USD Million)
  • TABLE 210 Middle East & Africa cancer stem cells therapy market size, by country, 2023 - 2032 (USD Million)
  • TABLE 211 Middle East & Africa cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 212 Middle East & Africa cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 213 Middle East & Africa cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 214 Middle East & Africa cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 215 Middle East & Africa cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 216 Middle East & Africa cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 217 Middle East & Africa cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 218 Middle East & Africa cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 219 South Africa cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 220 South Africa cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 221 South Africa cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 222 South Africa cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 223 South Africa cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 224 South Africa cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 225 South Africa cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 226 South Africa cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 227 Saudi Arabia cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 228 Saudi Arabia cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 229 Saudi Arabia cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 230 Saudi Arabia cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 231 Saudi Arabia cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 232 Saudi Arabia cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 233 Saudi Arabia cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 234 Saudi Arabia cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 235 Rest of Middle East & Africa cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 236 Rest of Middle East & Africa cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 237 Rest of Middle East & Africa cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 238 Rest of Middle East & Africa cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 239 Rest of Middle East & Africa cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 240 Rest of Middle East & Africa cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 241 Rest of Middle East & Africa cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 242 Rest of Middle East & Africa cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)

Charts & Figures

  • FIG 1 GMI report coverage: Critical research elements
  • FIG 2 Top-down approach
  • FIG 3 Market estimation and forecast methodology
  • FIG 4 Market forecasting methodology
  • FIG 5 Breakdown of primary participants
  • FIG 6 Cancer stem cells therapy industry 360 degree synopsis, 2018 - 2032
  • FIG 7 Growth potential analysis, by type
  • FIG 8 Growth potential analysis, by cancer type
  • FIG 9 Growth potential analysis, by end-user
  • FIG 10 Porter's analysis
  • FIG 11 PESTEL analysis
  • FIG 12 Company matrix analysis, 202
  • FIG 13 Competitive analysis of major market players, 2022
  • FIG 14 Competitive positioning matrix